BETAHISTINE HYDROCHLORIDE (SERC) IN CEREBROVASCULAR DISEASE: A PLACEBO-CONTROLLED STUDY

A double-blind, placebo-controlled, clinical study was performed to assess the effects of oral betahistine hydrochloride (Serc) on mental impairment, and physical disability in patients with established cerebrovascular disease. Fifty-three patients were admitted to the study during 18 months. Forty-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Age and ageing 1977-08, Vol.6 (3), p.179-184
Hauptverfasser:	PATHY, J., MENON, G., REYNOLDS, A., VAN STRIK, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Administration, Oral Aged Betahistine - administration & dosage Betahistine - therapeutic use Cerebrovascular Disorders - drug therapy Cerebrovascular Disorders - physiopathology Clinical Trials as Topic Drug Evaluation Female Humans Male Mental Processes - drug effects Mental Processes - physiology Middle Aged Placebos Psychological Tests Pyridines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!